The final results verify conclusions drawn by Bagli et al. [1], who performed a examine that integrated 10 patients diagnosed with CRAO who gained HBOT. Together with receiving twenty sessions of HBOT, oral acetazolamide and topical beta-blockers were being administered to the patients in the earliest probable time.HBOT is often a healthcare treatm